Gujarat Terce Laboratories Limited (BOM:524314)
40.05
+6.15 (18.14%)
At close: Apr 17, 2026
BOM:524314 Market Cap
BOM:524314 has a market cap or net worth of 264.13 million as of April 17, 2026. Its market cap has decreased by -46.67% in one year.
Market Cap
264.13M
Enterprise Value
260.64M
Revenue
483.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.05
Market Cap Chart
Since May 15, 2007, BOM:524314's market cap has increased from 29.41M to 264.13M, an increase of 798.09%. That is a compound annual growth rate of 12.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 264.13M | -22.07% |
| Dec 31, 2025 | 338.92M | -46.14% |
| Dec 31, 2024 | 629.24M | 197.65% |
| Dec 29, 2023 | 211.40M | 56.11% |
| Dec 30, 2022 | 135.42M | 0.05% |
| Dec 31, 2021 | 135.35M | 108.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Walpar Nutritions | 396.75M |
| Sandu Pharmaceuticals | 357.46M |
| Murae Organisor | 353.20M |
| ANG Lifesciences India | 317.97M |
| JFL Life Sciences | 305.21M |
| Deccan Health Care | 275.25M |
| Rekvina Laboratories | 245.10M |
| Cian Healthcare | 206.47M |